Soticlestat (TAK-935, OV935) is a first-in-class, potent, selective, and orally active cholesterol 24-hydroxylase (CH24H) inhibitor. Soticlestat has the potential for epilepsy syndromes research[1][2].
Molecular Weight:
373.45
Purity:
99.83
CAS Number:
[1429505-03-2]
Formula:
C23H23N3O2
Target:
Cytochrome P450
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
